Rob Blum

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.

Patrick J. Loehrer, KyungMann Kim, Seena C. Aisner et al. · Journal of Clinical Oncology · 1994 · 300 citations

Imaging of hypoxia with ¹⁸<scp>F</scp>‐<scp>FAZA PET</scp> in patients with locally advanced non‐small cell lung cancer treated with definitive chemoradiotherapy

Mateya Trinkaus, Rob Blum, Danny Rischin et al. · Journal of Medical Imaging and Radiation Oncology · 2013 · 64 citations

A comparison of fluorine‐18 fluoro‐deoxyglucose PET and technetium‐99m sestamibi in assessing patients with multiple myeloma

Linda Mileshkin, Rob Blum, John F. Seymour et al. · European Journal Of Haematology · 2003 · 59 citations